FDA Inspection 1286320 — Mayo Clinic Rochester, Division Of Transfusion Medicine
The FDA completed an inspection of Mayo Clinic Rochester, Division Of Transfusion Medicine on Sep 17, 2025 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 17, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Rochester, MN (United States)